AI Development

Google’s Isomorphic Labs in talks to raise over $2 billion for AI drug discovery

May 9, 2026 · High importance · markets
Editorial Analysis

Isomorphic Labs, Alphabet's AI-powered drug discovery company from Google DeepMind, is in advanced discussions to raise more than $2 billion in new funding, likely led by Thrive Capital. This highlights strong investor interest in applying frontier AI to biotechnology and pharmaceutical innovation.

At a Glance
Date
May 9, 2026
Importance
High 4/5
Category
markets
Axis of Change
Capital Concentration
Organizations
Google Isomorphic Labs
Models Affected
No specific model identified
Sources
  1. 01 economictimes.indiatimes.com
Related Developments
Sep 18, 2026 · markets

AI startup Mantic raises $25 million for forecasting systems
Sep 16, 2026 · markets

ByteDance completes $290 million fundraising for spun-off AI drug discovery unit
Sep 15, 2026 · markets

Bill Gates Foundation commits at least $1 billion to expand equitable AI access